TOP STORIES
Turing Pharma announced how it will move on in a post-Martin Shkreli world: expanding its board, seeking a new CEO and trimming its personnel. – CNBC, BusinessWire
Hillary Clinton rolled out a plan aimed at finding a cure for Alzheimer’s disease through a big increase in government research spending, $2 billion a year, which is a project that she would underwrite partly through higher taxes on wealthier Americans. — Wall Street Journal
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
LIFE SCIENCES
Another sign diabetes competition will be fierce next year: Sanofi submitted an FDA application for its one-day diabetes injection. It asked for a six-month review process. – Reuters
Complications with the ethics of drug pricing continue. For patients, it provides new challenges, even with old drugs. — New York Times
Orig3n has raised another $3 million to help grow their stem cell storage and regeneration services. – Triangle Business Journal
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Tissue processing company CryoLife Inc. will acquire mechanical heart valve company On-X Life Technologies. – Atlanta Business Chronicle
A new rabies treatment from Kamada will be seeking FDA approval by mid-2016. – Reuters
The FDA approved Zurampic lesinurad from AstraZeneca in combination with a xanthine oxidase inhibitor to treat hyperuricemia associated with gout. — BioCentury
Transgene SA announced that the results from its next phase study of immunotherapy in non-small cell lung cancer have been published in the peer-reviewed medical journal, The Lancet Oncology. — Business Wire
Emulate Inc. said Merck will use the biotech’s Emulate Small Airway Lung-Chip and Intestine-Chip technologies to predict organ responses to Merck’s discovery-stage candidates for undisclosed inflammatory diseases. — BioCentury
PAYERS/PROVIDERS
Hospital Corporation of America has agreed to pay the federal government and the state of Georgia $2 million to settle allegations medically unnecessary heart procedures were performed at an HCA hospital in Georgia. — Becker’s Hospital Review
UV robots might be the solution to killing germs in hospitals. — Mayo Clinic
POLITICS
Almost 8.3 million people have enrolled in Obamacare plans, putting the administration well ahead of last year’s total at the same point in the sign-up season. — The Hill
Ukraine’s health system is about to crumble. – Reuters
A LITTLE BIT EXTRA
Google is apparently in talks with Ford to help build its autonomous cars. — VentureBeat
Photo: WikiCommons
